Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Integra Lifesciences ( (IART) ) just unveiled an announcement.
Integra LifeSciences has adopted a change in control severance program effective January 1, 2025, providing severance and benefits to certain executives in the event of employment termination following a company change in control by December 31, 2025. The program aims to ensure stability and incentivize retention during potential transitions, impacting executive compensation and company operations if a change occurs.
More about Integra Lifesciences
Integra LifeSciences Holdings Corporation operates in the medical technology industry, specializing in products and services for tissue technologies and surgical specialties.
YTD Price Performance: -45.56%
Average Trading Volume: 883,830
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.83B
See more data about IART stock on TipRanks’ Stock Analysis page.
